Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited,...

FDA Recall #D-0239-2026 — Class II — November 17, 2025

Recall #D-0239-2026 Date: November 17, 2025 Classification: Class II Status: Ongoing

Product Description

Ondansetron ODT Tablets, USP 4mg, 1x10 unit dose tablets, Mfg: Glenmark Pharmaceuticals Limited, Repackaged by Preferred Pharmaceuticals NDC 68788-8666-01

Reason for Recall

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Recalling Firm

Preferred Pharmaceuticals, Inc. — Anaheim, CA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

575 1x10 Foil Blister Packs

Distribution

Natinowide in the USA

Code Information

Lot: J1325J, I1725P, EXP Date: 4/30/2027.

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated